{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:51:21Z","timestamp":1792158681119,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.autrev.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T06:31:11Z","timestamp":1354257071000},"page":"607-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Beh\u00e7et's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"12","author":[{"given":"Antonio-Javier","family":"Chamorro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Hern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.11.001_bb0005","article-title":"Revised international Chapel Hill consensus conference nomenclature of vasculitides","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.11.001_bb0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","article-title":"Behcet's syndrome","volume":"12","author":"Yazici","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2012.11.001_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Behcet's disease: an update","volume":"23","author":"Calamia","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0020","doi-asserted-by":"crossref","first-page":"e2011026","DOI":"10.4084\/mjhid.2011.026","article-title":"Behcet's syndrome and thrombosis","volume":"3","author":"Seyahi","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.autrev.2012.11.001_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","article-title":"Etiopathogenesis of Behcet's disease","volume":"9","author":"Mendoza-Pinto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.11.001_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00296-002-0258-z","article-title":"Plasma thrombomodulin levels in patients with Behcet's disease","volume":"23","author":"Duzgun","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.11.001_bb0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","article-title":"Activated protein C levels in Behcet's disease and risk of venous thrombosis","volume":"126","author":"Navarro","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2011.12.005","article-title":"Cytokines and Behcet's disease","volume":"11","author":"Zhou","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.11.001_bb0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07078.x","article-title":"Fibrinolytic inhibitor levels and polymorphisms in Behcet disease and their association with thrombosis","volume":"141","author":"Ricart","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0050","first-page":"S53","article-title":"Fibrinolytic activity and d-dimer levels in Behcet's syndrome","volume":"23","author":"Yurdakul","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","article-title":"Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin","volume":"112","author":"Espinosa","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2012.11.001_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000077824","article-title":"Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behcet's disease","volume":"33","author":"Ates","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.autrev.2012.11.001_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/gtmb.2011.0096","article-title":"Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor v, and prothrombin","volume":"16","author":"Dagan","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.autrev.2012.11.001_bb0070","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/ATVBAHA.110.207068","article-title":"Homocysteine in vascular Behcet disease: a meta-analysis","volume":"30","author":"La Regina","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0075","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/ard.2003.014241","article-title":"Thrombophilic factors are not the leading cause of thrombosis in Behcet's disease","volume":"63","author":"Leiba","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.11.001_bb0080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1160\/TH05-10-0659","article-title":"Thrombophilic risk factors and homocysteine levels in Behcet's disease in eastern Spain and their association with thrombotic events","volume":"95","author":"Ricart","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2012.11.001_bb0085","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","author":"International Study Group for Behcet's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2012.11.001_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.autrev.2012.11.001_bb0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2012.11.001_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2012.11.001_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2288-6-50","article-title":"Development and validation of MIX: comprehensive free software for meta-analysis of causal research data","volume":"6","author":"Bax","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0110","series-title":"Review Manager (RevMan) [computer program]. Version 5.0","year":"2008"},{"key":"10.1016\/j.autrev.2012.11.001_bb0115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/ard.54.10.860","article-title":"Activated protein C resistance caused by factor V Arg 506\u2192Gln mutation has no role in thrombotic manifestations of Behcet's disease","volume":"54","author":"Lesprit","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.11.001_bb0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2003.12.010","article-title":"Endothelial cell activation and hypercoagulability in ocular Behcet's disease","volume":"137","author":"Probst","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2012.11.001_bb0125","first-page":"247","article-title":"The role of promoter polymorphisims of FVII gene in Behcet patients with thrombosis","volume":"37","author":"Veli","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.autrev.2012.11.001_bb0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10067-010-1455-x","article-title":"Combined thrombophilic factors increase the risk of recurrent thrombotic events in Behcet's disease","volume":"29","author":"Yasar","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0135","first-page":"21","article-title":"Association between factor V Leiden gene mutation and systemic involvement in Behcet's disease","volume":"43","author":"Cebeci","year":"2009","journal-title":"Turkderm Arch Turk D"},{"key":"10.1016\/j.autrev.2012.11.001_bb0140","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","article-title":"Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease","volume":"35","author":"Gul","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0145","first-page":"2196","article-title":"Association of factor V Leiden with Behcet's disease","volume":"24","author":"Mammo","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01451044","article-title":"Thrombomodulin levels in Behcet's disease with and without the factor V Leiden mutation","volume":"17","author":"Gurgey","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0155","first-page":"496","article-title":"Factor V Leiden mutation in patients with Behcet's disease","volume":"25","author":"Oner","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","article-title":"Factor V Leiden mutation is associated with ocular involvement in Behcet disease","volume":"128","author":"Verity","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0165","first-page":"2404","article-title":"Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet's disease","volume":"26","author":"Mader","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0170","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","article-title":"Procoagulant mutations and venous thrombosis in Behcet's disease","volume":"38","author":"Gul","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2012.11.001_bb0175","first-page":"2849","article-title":"Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behcet's disease","volume":"27","author":"Toydemir","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0420.2003.00068.x","article-title":"Factor V Leiden and prothrombin gene G20210A mutations in ocular Behcet disease","volume":"81","author":"Batioglu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.autrev.2012.11.001_bb0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00296-003-0301-8","article-title":"Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behcet's disease","volume":"23","author":"Canataroglu","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2012.11.001_bb0190","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.87.8.1048","article-title":"Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behcet's disease","volume":"87","author":"Chen","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001721-200302000-00001","article-title":"Factor V Leiden mutation and PAI-1 gene 4G\/5G genotype in thrombotic patients with Behcet's disease","volume":"14","author":"Gurgey","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.autrev.2012.11.001_bb0200","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/bjo.2005.076836","article-title":"5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement","volume":"89","author":"Ozkul","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/art.20237","article-title":"Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis","volume":"51","author":"Silingardi","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.11.001_bb0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/PL00007469","article-title":"Association of factor V Leiden and prothrombin gene mutation with Behcet's disease","volume":"293","author":"Tursen","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2012.11.001_bb0215","first-page":"22","article-title":"Factor V Leiden mutation in Behcet's disease","volume":"9","author":"Soy","year":"2000","journal-title":"Ann Med Sci"},{"key":"10.1016\/j.autrev.2012.11.001_bb0220","first-page":"103","article-title":"Factor V leiden mutation in Behcet's disease and the relationship with clinical manifestations","volume":"68","author":"Mowla","year":"2010","journal-title":"Tehran Univ Med J"},{"key":"10.1016\/j.autrev.2012.11.001_bb0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jbspin.2010.02.022","article-title":"A study on thrombophilic factors in Italian Behcet's patients","volume":"77","author":"Caramaschi","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"Suppl. 60","key":"10.1016\/j.autrev.2012.11.001_bb0230","first-page":"105","article-title":"Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphism in patients with Behcet's disease","volume":"28","author":"Shahram","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2012.11.001_bb0235","first-page":"1696","article-title":"Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease","volume":"18","author":"Karakus","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.autrev.2012.11.001_bb0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2012.11.001_bb0245","doi-asserted-by":"crossref","first-page":"e2011037","DOI":"10.4084\/mjhid.2011.037","article-title":"Epidemiology of activated protein C resistance and factor V Leiden mutation in the Mediterranean region","volume":"3","author":"Jadaon","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.autrev.2012.11.001_bb0250","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Behcet's disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212002807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T04:11:51Z","timestamp":1562386311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212002807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1568997212002807"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.11.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Beh\u00e7et's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2012.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}